It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Here we report a pilot-sized study to compare the taxonomic composition of sputum microbiome in 17 newly-diagnosed lung cancer (LC) patients and 17 controls. Another object was to compare the representation of individual bacterial genera and species in sputum with the frequency of chromosomal aberrations in the blood lymphocytes of LC patients and in controls. Both groups were male; average age 56.1 ± 11.5 in patients and 55.7 ± 4.1 in controls. Differences in the species composition of bacterial communities in LC patients and controls were significant (pseudo-F = 1.94; p = 0.005). Increased prevalence in LC patients was detected for the genera Haemophilus and Bergeyella; whereas a decrease was observed for the genera Atopobium, Stomatobaculum, Treponema and Porphyromonas. Donors with high frequencies of chromosomal aberrations had a significant reduction in the microbiome of representatives of the genus Atopobium in the microbiome and a simultaneous increase in representatives of the species Alloprevotella compared to donors with a low level of chromosomal aberrations in lymphocytes. Thus, a comparison of the bacterial composition in the sputum of donors with cytogenetic damages in theirs lymphocytes, warrants further investigations on the potential role of microorganisms in the process of mutagenesis in somatic cells of the host body.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Kemerovo State University, Kemerovo, Russian Federation (GRID:grid.79013.3c) (ISNI:0000 0001 2186 3188)
2 Kemerovo State University, Kemerovo, Russian Federation (GRID:grid.79013.3c) (ISNI:0000 0001 2186 3188); Institute of Living Systems Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation (GRID:grid.410686.d) (ISNI:0000 0001 1018 9204); Tumor Biology and Cell Biology (MTC), Department of Microbiology, Stockholm, Sweden (GRID:grid.451940.d) (ISNI:0000 0004 0435 7963)
3 Institute of Cytology and Genetics SB RAS, Novosibirsk, Russian Federation (GRID:grid.418953.2)
4 Kemerovo State University, Kemerovo, Russian Federation (GRID:grid.79013.3c) (ISNI:0000 0001 2186 3188); Federal Research Center of Coal and Coal Chemistry of Siberian Branch of the Russian Academy of Sciences, Institute of Human Ecology, Kemerovo, Russian Federation (GRID:grid.79013.3c)
5 City Hospital #40, St. Petersburg, Russian Federation (GRID:grid.79013.3c)